Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07571304
Dual-Task Training in Pediatric Multiple SclerosisIstanbul University - CerrahpasaRecruitingNot Applicable
NCT07571304Recruiting
Not Applicable
Dual-Task Training in Pediatric Multiple SclerosisIstanbul University - Cer...
NCT07570576
Front-of-package Warning Labels for Sugar Content in Sugar-sweetened BeveragesChinese University of Hong KongNot Yet RecruitingNot Applicable
NCT07570576Not Yet Recruiting
Not Applicable
Front-of-package Warning Labels for Sugar Content in Sugar-sweetened BeveragesChinese University of Hon...
NCT07569770
Comparing High-Protein and Low-Protein Multi-Ingredient Supplements for Body Composition and Performance in Elite Rugby PlayersUniversity of TaipeiCompletedNot Applicable
NCT07569770Completed
Not Applicable
Comparing High-Protein and Low-Protein Multi-Ingredient Supplements for Body Com...University of Taipei
NCT07569471
REFLECT: A Novel Group-Based Compassion-Focussed Cognitive Behavioural Approach to Core Beliefs in PsychosisUniversity of TorontoRecruitingNot Applicable
NCT07569471Recruiting
Not Applicable
REFLECT: A Novel Group-Based Compassion-Focussed Cognitive Behavioural Approach...University of Toronto
NCT07570017
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaGuangzhou Lupeng Pharmaceutical Company LTD.Not Yet RecruitingPhase 1
NCT07570017Not Yet Recruiting
Phase 1
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refrac...Guangzhou Lupeng Pharmace...
NCT07571005
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaNovo Nordisk A/SNot Yet RecruitingPhase 3
NCT07571005Not Yet Recruiting
Phase 3
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps...Novo Nordisk A/S
NCT07569731
Fibrous Dysplasia: An Epidemiological and Correlational Study of Multimodal DataIstituto Ortopedico RizzoliRecruiting
NCT07569731Recruiting
—
Fibrous Dysplasia: An Epidemiological and Correlational Study of Multimodal DataIstituto Ortopedico Rizzo...
NCT07569029
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan AntibodiesDepartment of Health and Human Services (HHS)Not Yet RecruitingPhase 1
NCT07569029Not Yet Recruiting
Phase 1
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA...Department of Health and...
NCT07571798
The Difference of Two and Three Fluoroscopic Views of Sacrum for Percutaneous Sacroiliac Screw Insertion in High Energy Posterior Pelvic Ring Injured PatientsChonburi hospitalActive Not RecruitingNot Applicable
NCT07571798Active Not Recruiting
Not Applicable
The Difference of Two and Three Fluoroscopic Views of Sacrum for Percutaneous Sa...Chonburi hospital
NCT07570082
Drug-Drug Interaction Study of Atumelnant in Healthy ParticipantsCrinetics Pharmaceuticals Inc.RecruitingPhase 1
NCT07570082Recruiting
Phase 1
Drug-Drug Interaction Study of Atumelnant in Healthy ParticipantsCrinetics Pharmaceuticals...
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07570186
Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy Male ParticipantsOnconic Therapeutics Inc.Not Yet RecruitingPhase 1
NCT07570186Not Yet Recruiting
Phase 1
Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy...Onconic Therapeutics Inc.
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07568782
Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Immune Response in Glioblastoma: A Kinetic Analysis of Immune Biomarkers.Lille UniversityNot Yet Recruiting
NCT07568782Not Yet Recruiting
—
Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Im...Lille University
NCT07570589
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)Centre Hospitalier Universitaire de NiceNot Yet Recruiting
NCT07570589Not Yet Recruiting
—
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evol...Centre Hospitalier Univer...
NCT07571395
Median Nerve Electromyography to Monitor Intraoperative Neuromuscular FunctionPongrácz AdriennNot Yet Recruiting
NCT07571395Not Yet Recruiting
—
Median Nerve Electromyography to Monitor Intraoperative Neuromuscular FunctionPongrácz Adrienn
NCT07569380
Long-Term Outcomes After CDI: FMT Versus Antibiotic-Only TreatmentRegion VästerbottenNot Yet Recruiting
NCT07569380Not Yet Recruiting
—
Long-Term Outcomes After CDI: FMT Versus Antibiotic-Only TreatmentRegion Västerbotten
NCT07568769
Exteroceptive Stimulation for Facial Palsy After StrokeUniversity of FaisalabadCompletedNot Applicable
NCT07568769Completed
Not Applicable
Exteroceptive Stimulation for Facial Palsy After StrokeUniversity of Faisalabad
NCT07570264
LEXURE for Post-Stroke Aphasia: A Randomized, Evaluator-Blinded, Confirmatory TrialNunaps IncRecruitingNot Applicable
NCT07570264Recruiting
Not Applicable
LEXURE for Post-Stroke Aphasia: A Randomized, Evaluator-Blinded, Confirmatory Tr...Nunaps Inc
Result Breakdown
Not yet recruiting9 (45%)
Recruiting7 (35%)
Completed2 (10%)
Active, not recruiting2 (10%)
not_applicable8 (40%)
Not Specified6 (30%)
Phase 14 (20%)
Phase 31 (5%)
Phase 21 (5%)